2023 annual financial data
Jasper Therapeutics 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -68.86M USD and net income was -64.47M USD.
Operating cash flow was -52.07M USD.
Get free Jasper Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -68.86M USD
- Net income
- -64.47M USD
- Operating cash flow
- -52.07M USD